Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-04-06

Clinical Trial Update: A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece

View source ↗

Summary

A completed cross-sectional study conducted in Greece evaluated the prevalence of gastroesophageal reflux disease among patients with upper GI symptoms and docu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED